HMS
AERI

Hanseatic Management Services’s Aerie Pharmaceuticals AERI Stock Holding History

Hanseatic Management Services’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,197
Closed -$397K – 180
2021
Q1 		$397K Buy
+22,197
New +$383K 0.79% 50
2018
Q1 		– Sell
-16
Closed -$1K – 496
2017
Q4 		$1K Hold
16
– – ﹤0.01% 413
2017
Q3 		$1K Hold
16
– – ﹤0.01% 402
2017
Q2 		$1K Buy
+16
New +$745 ﹤0.01% 397

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Hanseatic Management Services's AERI Position: Q2 2021 in Review

Hanseatic Management Services sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 22,197 shares — an estimated $397K sold.

Hanseatic Management Services first reported a position in AERI in Q2 2017 and held it in 4 quarters. The position peaked at $397K in Q1 2021. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

  • Hanseatic Management Services reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Hanseatic Management Services sold 22,197 Aerie Pharmaceuticals shares in Q2 2021, an estimated $397K.
  • Hanseatic Management Services first reported a position in Aerie Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Hanseatic Management Services's Aerie Pharmaceuticals position peaked at $397K in Q1 2021.
  • 142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on Hanseatic Management Services's 13F filing for Q2 2021, filed 30 Jul 2021.